James F. Polewaczyk, Executive Vice President at IDEXX LABORATORIES INC /DE (IDXX), sold 16,208 shares at $558.88 ($9.1M) on 2024-03-06, disclosed to the SEC on 2024-03-07.
Open-market sale of $9.1M IDXX by Executive Vice President. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $557.94 | 4,134 | $2.3M | 25.5% |
| 2 | $557.94 | 4,134 | $2.3M | 25.5% |
| 3 | $558.88 | 3,290 | $1.8M | 20.3% |
| 4 | $558.88 | 3,290 | $1.8M | 20.3% |
| 5 | $559.33 | 680 | $380K | 4.2% |
| 6 | $559.33 | 680 |
| $380K |
| 4.2% |
| Total | $558.44 avg | 16,208 | $9.1M | 100% |
| Filing → |
| IDXX | SELL | 2021-12-01 | $2.9M | — | Filing → |
| IDXX | SELL | 2021-06-01 | $11.2M | — | Filing → |
| IDXX | SELL | 2020-05-12 | $9.7M | — | Filing → |